Chitosan-dextran sulfate nanoparticles for delivery of an anti-angiogenesis peptide

被引:118
作者
Chen, Y [1 ]
Mohanraj, VJ
Parkin, JE
机构
[1] Curtin Univ Technol, Sch Pharm, Western Australian Biomed Res Inst, Perth, WA 6845, Australia
[2] Fourrts India Labs Private Ltd, Madras, Tamil Nadu, India
来源
LETTERS IN PEPTIDE SCIENCE | 2003年 / 10卷 / 5-6期
关键词
chitosan; dextran sulphate; nanoparticles; peptide delivery; sustained-release;
D O I
10.1007/BF02442596
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A novel nanoparticle delivery system has been developed by employing the oppositely charged polymers chitosan (CS) and dextran sulfate (DS), and a simple coacervation process. Under the conditions investigated, the weight ratio of the two polymers is identified as a determining factor controlling particle size, surface charge, entrapment efficiency and release characteristics of the nanoparticles produced. Particles of 223 nm mean diameter were produced under optimal conditions with a zeta potential of approximately -32.6 mV. A maximum of 75% anti-angiogenesis peptide entrapment efficiency was achieved with a CS:DS weight ratio of 0.59:1. The same nanoparticle formulation also showed slow and sustained peptide release over a period of 6 days. In contrast, the formulation containing a lower ratio of CS:DS (0.5:1) was found to have reduced entrapment efficiency and more rapid peptide release characteristics. The results of this study suggest that physicochemical and release characteristics of the CS-DS nanoparticles can be modulated by changing ratios of two ionic polymers. The novel CS-DS nanoparticles. prepared by the coacervation process have potential as a carrier for small peptides.
引用
收藏
页码:621 / 629
页数:9
相关论文
共 19 条
[11]   Polysaccharide colloidal particles as delivery systems for macromolecules [J].
Janes, KA ;
Calvo, P ;
Alonso, MJ .
ADVANCED DRUG DELIVERY REVIEWS, 2001, 47 (01) :83-97
[12]   Chitosan-DNA nanoparticles as gene carriers: synthesis, characterization and transfection efficiency [J].
Mao, HQ ;
Roy, K ;
Troung-Le, VL ;
Janes, KA ;
Lin, KY ;
Wang, Y ;
August, JT ;
Leong, KW .
JOURNAL OF CONTROLLED RELEASE, 2001, 70 (03) :399-421
[13]  
Paul W, 2000, STP PHARMA SCI, V10, P5
[14]   Mucoadhesive nanoparticulate systems for peptide drug delivery [J].
Takeuchi, H ;
Yamamoto, H ;
Kawashima, Y .
ADVANCED DRUG DELIVERY REVIEWS, 2001, 47 (01) :39-54
[15]   Formulation and characterization of DNA-polyethylenimine-dextran sulfate nanoparticles [J].
Tiyaboonchai, W ;
Woiszwillo, J ;
Middaugh, CR .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2003, 19 (04) :191-202
[16]   Insulin containing polyethylenimine-dextran sulfate nanoparticles [J].
Tiyaboonchai, W ;
Woiszwillo, J ;
Sims, RC ;
Middaugh, CR .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2003, 255 (1-2) :139-151
[17]   Stealth PLA-PEG nanoparticles as protein carriers for nasal administration [J].
Tobío, M ;
Gref, R ;
Sánchez, A ;
Langer, R ;
Alonso, MJ .
PHARMACEUTICAL RESEARCH, 1998, 15 (02) :270-275
[18]   Effect of molecular structure of chitosan on protein delivery properties of chitosan nanoparticles [J].
Xu, YM ;
Du, YM .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2003, 250 (01) :215-226
[19]   Prolonged hypoglycemic effect of insulin-loaded polybutylcyanoacrylate nanoparticles after pulmonary administration to normal rats [J].
Zhang, Q ;
Shen, ZC ;
Nagai, T .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2001, 218 (1-2) :75-80